HIV and hepatitis coinfection
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
This is the study of 3,000 patients receiving one of 10 IFN based regimens assessing impact of PEG-IFN/RBV in fibrosis and activity in responders and nonresponders, and cirrhotics.
The findings are interesting and were reported in Gastroenterology. This report contains tables and charts from the published study.